--- title: "Xintian Pharma's subsidiary has obtained an invention patent for the \"Ginkgo Biloba Water Decoction Fingerprint Map\"" type: "News" locale: "en" url: "https://longbridge.com/en/news/255741449.md" description: "Guiyang Xintian Pharma Co., Ltd.'s wholly-owned subsidiary Shanghai ShuoFang Pharmaceutical Technology Co., Ltd. has obtained an invention patent issued by the National Intellectual Property Administration, with the patent content being a method for detecting the fingerprint spectrum of ginkgo biloba water decoction. This patent will help in detecting the chemical components of ginkgo biloba medicinal materials, ensuring product quality, and will be used in new drug production. Although it does not have a significant impact on the company's operations, it helps to improve intellectual property protection and enhance core competitiveness" datetime: "2025-09-03T08:35:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/255741449.md) - [en](https://longbridge.com/en/news/255741449.md) - [zh-HK](https://longbridge.com/zh-HK/news/255741449.md) --- # Xintian Pharma's subsidiary has obtained an invention patent for the "Ginkgo Biloba Water Decoction Fingerprint Map" Recently, Guizhou Xintian Pharma Co., Ltd.'s wholly-owned subsidiary, Shanghai ShuoFang Pharmaceutical Technology Co., Ltd., received the invention patent certificate for "A Method for Detecting the Fingerprint Spectrum of Ginkgo Biloba Water Decoction and Its Fingerprint Spectrum" issued by the National Intellectual Property Administration. The patent application date is June 19, 2023, and the authorization announcement date is August 29, 2025. This patent can comprehensively detect the chemical components of ginkgo medicinal materials, providing a basis for ensuring product quality, and will be used in the production of related new drugs in the future. Although it has no significant impact on the company's production and operations, it is beneficial for improving the intellectual property protection system and enhancing core competitiveness ### Related Stocks - [002873.CN](https://longbridge.com/en/quote/002873.CN.md) ## Related News & Research - [16:51 ETBeverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons](https://longbridge.com/en/news/286966075.md) - [Orkla’s OV UK Buys Phoenix Brands to Boost Sweet Ingredients Footprint](https://longbridge.com/en/news/286763926.md) - [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md) - [](https://longbridge.com/en/news/286948461.md) - [BCAL Diagnostics Expands National Access to Early Cancer Detection Blood Tests](https://longbridge.com/en/news/286850851.md)